<p>The invention provides preferred dosage ranges, maximum concentrations, average concentrations and monitoring regimes for use in treatment of Alzheimer's disease using antibodies to Aß. The invention also provides monitoring regimes that can assess changes in symptoms or signs of the patient following treatment.</p>
申请公布号
WO2010044803(A1)
申请公布日期
2010.04.22
申请号
WO2008US80370
申请日期
2008.10.17
申请人
ELAN PHARMA INTERNATIONAL LIMITED;WYETH LLC;LIEBERBURG, IVAN;CALLAWAY, JIM;GRUNDMAN, MICHAEL
